Doktorumuz Hakkında
Prof. Dr. Yelda Kapıcıoğlu (Dermatolog, Deri ve Zührevi Hastalıklar Uzmanı )
Prof Dr Yelda Kapıcıoğlu, 1991 yılında Çukurova Üniversitesi, Tıp Fakültesi bitirerek, Samsun Bafra’da mecburi hizmetine başladı, 1996 yılında İnönü Üniversitesi, Tıp Fakültesi Dermatoloji Anabilim Dalında Dermatoloji ihtisasına başladı. 1999 yılında uzman olduktan sonra 2000 yılında Dermatolojik Cerrahi ve Otoimmün büllöz hastalıklar alanında Çukurova Üniversitesi, Dermatoloji Anabilim dalında çalıştı. 2005 yılında Doçent, 2011 yılında profesör oldu.
Estetik, Kozmetik ve Lazer Dermatoloji alanında deneyimlerini geliştirmek üzere 2011 yılında The Baumann Cosmetic & Research Institute, Miami/ USA’de bulundu. 2014-2018 yılları arasında İnönü Üniversitesi, Dermatoloji Anabilim dalı Başkanlığını yürüttü ve Estetik ve Kozmetik Ünitesini Kurdu. Uluslararası 66 ve Ulusal 56 olmak üzere toplam 122 adet makalesi olup H index:20 dir. Ayrıca toplamda 36 adet Ulusal konferans sunumları ve kurslarında görev almış olup Estetik ve Kozmetik Dermatoloji Derneği Kurucu Yönetim kurulu ve halen yönetim kurulu üyesi olarak görev yapmaktadır.
İlgi Alanları:
Estetik – Kozmetik Dermatoloji Uygulamaları ve Antiaging, Akne, Rozase, Demodikozis ve Fasiyal eritem (Kırmızı yüz),
Enerji Bazlı Cihazlar (Lazerler, ışık sistemleri, iğneli radyofrekans, HİFU vb) ile antiaging ve tedaviler
Saç Hastalıkları
Genel Dermatoloji: Sedef Hastalığı, Behçet Hastalığı, Otoimmün büllöz hastalıklar (Pemfigus, pemfigoid vb) ve Ekzemalar ilgi alanlarıdır.
Bilimsel Dernek Üyelikler:
Estetik ve Kozmetik Dermatoloji Derneği
Türk Dermatoloji Derneği
Deri ve Zührevi Hastalıklar Derneği
Dermatolojik Cerrahi Derneği
Yayınlar:
66- Comparison of the efficacies of polycaprolactone filler and lidocaine-added filler on neocollagenesis in a rat model. Sezer S, Sarac G, Gul M, Zayman E, Kapicioglu Y.J Cosmet Dermatol. 2022 Aug;21(8):3327-3333. doi: 10.1111/jocd.14664. Epub 2021 Dec 11.
65- A new treatment option for poikiloderma of Civatte: 577 nm pro-yellow laser.
Sarac G, Kapicioglu Y, Cenk H.J Cosmet Dermatol. 2022 Jan;21(1):316-319.
64- Does Systemic Isotretinoin Treatment Constitute a Predisposition to Allergic Sensitization?
Cenk H, Kapicioglu Y, Yologlu S.Skinmed. 2021 Feb 1;19(1):28-34. eCollection 2021.
63- Psychiatric morbidity in children and adolescents with dermatological disorders.
Miniksar DY, Özcan ÖÖ, Cenk H, Kapıcıoğlu Y, Polat A.Scand J Child Adolesc Psychiatr Psychol. 2021 Jan 29;9:1-8.
62- Comparison of polycaprolactone and calcium hydroxylapatite dermal fillers in a rat model.
Yanatma I, Sarac G, Gul M, Gul S, Kapicioglu Y.Dermatol Ther. 2021 Jan;34(1):e14716..
Sarac G, Kapicioglu Y, Cenk H.Dermatol Ther. 2021 Jan;34(1):e14611.
60- Recurrent angiolymphoid hyperplasia with eosinophilia during several pregnancies.
Cenk H, Kapicioglu Y, Sarac G, Sener S, Sahin N.Dermatol Online J. 2020 Aug 15;26(8):13030/qt0131j1kh.
59- Intravascular lymphoma presenting with paraneoplastic syndrome.
Cenk H, Sarac G, Karadağ N, Berktas HB, Sahin I, Sener S, Kisaciik D, Kapicioglu Y.Dermatol Online J. 2020 Aug 15;26(8):13030/qt08252906.
58- Increased frequency of Demodex blepharitis in rosacea and facial demodicosis patients.
Sarac G, Cankaya C, Ozcan KN, Cenk H, Kapicioglu YK.J Cosmet Dermatol. 2020 May;19(5):1260-1265.
57- Efficacy of 577-nm Pro-Yellow laser in port wine stain treatment.
Sarac G, Kapicioglu Y. Dermatol Ther. 2019 Nov;32(6):e13078.
Bilgic-Temel A, Özgen Z, Harman M, Kapıcıoğlu Y, Uzun S.Pediatr Dermatol. 2019 Sep;36(5):646-650.
55- Effectiveness of topical Nigella sativa for vitiligo treatment.
Sarac G, Kapicioglu Y, Sener S, Mantar I, Yologlu S, Dundar C, Turkoglu M, Pekmezci E.Dermatol Ther. 2019 Jul;32(4):e12949.
54- Comparison of Antiaging Effects on Rat Skin of Cog Thread and Poly-L-Lactic Acid Thread.
Kapicioğlu Y, Gül M, Saraç G, Yiğitcan B, Gözükara H.Dermatol Surg. 2019 Mar;45(3):438-445.
Kapicioglu Y, Sarac G, Cenk H. Lasers Med Sci. 2019 Feb;34(1):93-98.
52- Determination of sunscreen and cosmetic product use awareness in adolescents Sarac G , Kayhan Tetik B , Sener S , Mantar I , Kapicioglu Y Annals of Medical Research 2019;26(2):236-9
51- Management of complications of vitamin E injections into the face.
Sarac G, Kapicioglu Y, Sener S, Cenk H, Akatli A.Dermatol Ther. 2018 Sep;31(5):e12621.
50- Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey.
Uzun S, Gürel MS, Durdu M, Akyol M, Fettahlıoğlu Karaman B, Aksoy M, Aytekin S, Borlu M, İnan Doğan E, Doğramacı ÇA, Kapıcıoğlu Y, Akman-Karakaş A, Kaya TI, Mülayim MK, Özbel Y, Özensoy Töz S, Özgöztaşı O, Yeşilova Y, Harman M.Int J Dermatol. 2018 Aug;57(8):973-982.
Acikgoz N, Kurtoğlu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N.Angiology. 2018 Jan;69(1):65-70.
48- Epidemiology of Pemphigus in Turkey: One-year Prospective Study of 220 Cases.
Yayli S, Harman M, Baskan EB, Karakas AA, Genc Y, Turk BG, Demirsoy EO, Gunasti S, Bilgili SG, Ilter N, Ferahbas A, Savk E, Afsar FS, Aytekin S, Kaya TI, Hayta SB, Ozgen Z, Gurel MS, Caliskan E, Balci DD, Gungor S, Kapicioglu Y, Ozuguz P, Aktan S, Dogramaci A, Kokcam I, Onsun N, Seckin D, Durdu M, Dursun R, Daye M, Dilek N, Karabacak E, Temel AB, Erdem C, Altun E, Gungor D, Kartal D, Akyol M, Koku Aksu EK, Uzun S.Acta Dermatovenerol Croat. 2017 Oct;25(3):181-188.
47- CSF flow patterns in the brain in patients with neuro-Behçet disease and Behçet disease.
Ünlü S, Doğan M, Kapicioğlu Y, Kamişli S, Öner S, Yildirim IO, Öztürk M.Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3906-3910.
Turan N, Kapıcıoğlu Y, Saraç G.Turkiye Parazitol Derg. 2017 Sep;41(3):143-147.
45- Is the periodontal status a risk factor for the development of psoriasis?
Sarac G, Kapicioglu Y, Cayli S, Altas A, Yologlu S.Niger J Clin Pract. 2017 Apr;20(4):474-478.
Taşolar H, Taşolar S, Kurtuluş D, Altun B, Bayramoğlu A, Otlu YÖ, Ballı M, Çetin M, Altunışık N, Kapıcıoğlu Y, Pekdemir H.J Ultrasound Med. 2014 Aug;33(8):1393-400.
43- Evaluation of vertebral artery involvement by Doppler sonography in patients with Behçet disease.
Taşolar S, Doğan M, Taşolar H, Kahraman A, Kamışlı S, Doğan A, Yıldırım O, Kapıcıoğlu Y.J Ultrasound Med. 2014 May;33(5):811-6.
Ozdemir R, Yagmur J, Acikgoz N, Cansel M, Karincaoglu Y, Ermis N, Pekdemir H, Arslan AK.Kardiol Pol. 2018;76(2):413-417.
41- Isokinetic Evaluation of Knee Extensor/Flexor Muscle Strength in Behcet’s Patients.
Durmus B, Emre S, Sahin N, Karincaoglu Y, Dogan E, Baysal O, Ersoy Y, Altay Z.Acta Reumatol Port. 2015 Oct-Dec;40(4):348-54.
40- Isokinetic Evaluation of Knee Extensor/Flexor Muscle Strength in Behcet’s Patients.
Durmus B, Emre S, Sahin N, Karincaoglu Y, Dogan E, Baysal O, Ersoy Y, Altay Z.Acta Reumatol Port. 2014 Aug 24. Online ahead of print.
39- Assessment of atrial conduction time in patients with Behçet’s disease.
Cansel M, Yagmur J, Taşolar H, Karincaoglu Y, Ermis N, Acikgoz N, Bayramoglu A, Otlu O, Eyyüpkoca F, Pekdemir H, Ozdemir R. Acta Reumatol Port. 2014 Jan-Mar;39(1):29-36.
Gül IG, Kartalcı Ş, Cumurcu BE, Karıncaoğlu Y, Yoloğlu S, Karlıdağ R.J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1244-51.
37- The ocular surface in the Behçet’s disease patient. Gunduz A, Cumurcu T, Demirel EE, Akpolat N, Karıncaoglu Y. Can J Ophthalmol. 2012 Oct;47(5):429-34..
Aktürk E, Yağmur J, Kurtoğlu E, Ermis N, Acikgoz N, Sener S, Karakuş Y, Aktürk S, Karincaoğlu Y, Pekdemir H, Özdemir R.Eur Heart J Cardiovasc Imaging. 2012 Aug;13(8):650-5.
35- Brain perfusion MRI findings in patients with Behcet’s disease.
Alkan A, Goktan A, Karincaoglu Y, Kamisli S, Dogan M, Oztanir N, Turan N, Kocakoc E.ScientificWorldJournal. 2012;2012:261502.
Yagmur J, Sener S, Acikgoz N, Cansel M, Ermis N, Karincaoglu Y, Tasolar H, Karakus Y, Pekdemir H, Ozdemir R.Eur J Echocardiogr. 2011 Jul;12(7):536-41.
Acikgoz N, Ermiş N, Yağmur J, Cansel M, Karincaoğlu Y, Ataş H, Cuglan B, Barutcu I, Pekdemir H, Özdemir R.Angiology. 2011 May;62(4):296-300.
32- Increased mean platelet volume in Behçet’s disease with thrombotic tendency.
Acikgoz N, Karincaoglu Y, Ermis N, Yagmur J, Atas H, Kurtoglu E, Cansel M, Barutcu I, Pekdemir H, Ozdemir R.Tohoku J Exp Med. 2010 Jun;221(2):119-23.
31- Pulsed dye laser in the treatment of nail psoriasis.
Oram Y, Karincaoğlu Y, Koyuncu E, Kaharaman F.Dermatol Surg. 2010 Mar;36(3):377-81. doi: 10.1111/j.1524-4725.2009.01448.x. Epub 2010 Jan 19.
30- Evaluation of 60 patients with pilonidal sinus treated with laser epilation after surgery.
Oram Y, Kahraman F, Karincaoğlu Y, Koyuncu E.Dermatol Surg. 2010;36(1):88-91. doi: 10.1111/j.1524-4725.2009.01387.x. Epub 2009 Dec 4.
29- Is Demodex folliculorum an aetiological factor in seborrhoeic dermatitis?
Karincaoglu Y, Tepe B, Kalayci B, Atambay M, Seyhan M.Clin Exp Dermatol. 2009 Dec;34(8):e516-20. doi: 10.1111/j.1365-2230.2009.03343.x. Epub 2009 May 22.
28- Incontinentia pigmenti: a case report and literature review.
Emre S, Firat Y, Güngör S, Firat AK, Karincaoğlu Y.Turk J Pediatr. 2009 Mar-Apr;51(2):190-4.
27- A demodicosis case which responded to systemic ivermectin.
Karincaoglu Y, Miman O, Kalayci B, Aycan OM, Atambay M.Eur J Dermatol. 2009 Mar-Apr;19(2):189-90. doi: 10.1684/ejd.2008.0613. Epub 2009 Jan 20.
26- What is the importance of Demodex folliculorum in Behçet’s disease?
Emre S, Aycan OM, Atambay M, Bilak S, Daldal N, Karincaoglu Y.Turkiye Parazitol Derg. 2009;33(2):158-61.
25- Vitiligo koebnerized by behçet disease genital ulceration.
Karincaoglu Y, Kalayci B, Tepe B.Am J Clin Dermatol. 2009;10(4):268-70. doi: 10.2165/00128071-200910040-00008.PMID: 19489661
24- The prevalence of Demodex folliculorum on the scrotum and male perineal skin.
Uğraş M, Miman O, Karincaoglu Y, Atambay M.Turkiye Parazitol Derg. 2009;33(1):28-31.
23- Pseudozoster clinical presentation of Demodex infestation after prolonged topical steroid use.
Karincaoglu Y, Tepe B, Kalayci B, Seyhan M.Clin Exp Dermatol. 2008 Nov;33(6):740-2.
22- Demographic and clinical properties of juvenile-onset Behçet’s disease: A controlled multicenter study. Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, Usta A, Kandi B, Durusoy C, Seyhan M, Utas S, Saricaoglu H, Ozden MG, Uzun S, Tursen U, Cicek D, Donmez L, Alpsoy E.J Am Acad Dermatol. 2008 Apr;58(4):579-84.
21- Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study.
Alpsoy E, Donmez L, Onder M, Gunasti S, Usta A, Karincaoglu Y, Kandi B, Buyukkara S, Keseroglu O, Uzun S, Tursen U, Seyhan M, Akman A.Br J Dermatol. 2007 Nov;157(5):901-6.
20- High prevalence of glucose metabolism disturbance in patients with lichen planus.
Seyhan M, Ozcan H, Sahin I, Bayram N, Karincaoğlu Y.Diabetes Res Clin Pract. 2007 Aug;77(2):198-202.
19- Erythema multiforme due to diphtheria-pertussis-tetanus vaccine.
Karincaoğlu Y, Aki T, Erguvan-Onal R, Seyhan M.Pediatr Dermatol. 2007 May-Jun;24(3):334-5.
18- Psoriasis in childhood and adolescence: evaluation of demographic and clinical features.
Seyhan M, Coşkun BK, Sağlam H, Ozcan H, Karincaoğlu Y.Pediatr Int. 2006 Dec;48(6):525-30.
Aki T, Karincaoglu Y, Seyhan M, Batcioglu K.Clin Exp Dermatol. 2006 Jul;31(4):583-7.
16- Scalp ulcer as first sign of cholangiocarcinoma.
Dogan G, Karincaoglu Y, Karincaoglu M, Aydin NE.Am J Clin Dermatol. 2006;7(6):387-9.
15- Propylthiouracil-induced vasculitic oral ulcers with anti-neutrophil cytoplasmic antibody.
Karincaoglu Y, Esrefoglu M, Aki T, Mizrak B.J Eur Acad Dermatol Venereol. 2006 Jan;20(1):120-2.
14- Monilethrix: improvement with acitretin.
Karincaoglu Y, Coskun BK, Seyhan ME, Bayram N.Am J Clin Dermatol. 2005;6(6):407-10. doi: 10.2165/00128071-200506060-00008.PMID: 16343029
13- Incidence of Demodex folliculorum in patients with end stage chronic renal failure.
Karincaoglu Y, Esrefoglu Seyhan M, Bayram N, Aycan O, Taskapan H. Ren Fail. 2005;27(5):495-9.
12- Calcium acetate-induced linear fixed drug eruption.
Coskun B, Saral Y, Ozturk P, Karincaoglu Y, Cobanoglu B.Dermatology. 2005;210(3):244-5.
11- An unusual complication of erythema multiforme and its treatment.
Karincaoglu Y, Coskun BK, Seyhan M.Skinmed. 2005 Jan-Feb;4(1):53-5. doi:
10- The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis.
Karincaoglu Y, Batcioglu K, Erdem T, Esrefoglu M, Genc M.J Oral Pathol Med. 2005 Jan;34(1):7-12.
9- Atypical clinical form of cutaneous leishmaniasis: erysipeloid form.
Karincaoglu Y, Esrefoglu M, Ozcan H.Int J Dermatol. 2004 Nov;43(11):827-9.
Karincaoglu Y, Bayram N, Aycan O, Esrefoglu M.J Dermatol. 2004 Aug;31(8):618-26.
7- Density of Demodex folliculorum in haematological malignancies.
Seyhan ME, Karincaoğlu Y, Bayram N, Aycan O, Kuku I.J Int Med Res. 2004 Jul-Aug;32(4):411-5..
Bahceci F, Sari R, Sarikaya M, Atik E, Karincaoglu Y, Sevinc A.J Natl Med Assoc. 2004 Jun;96(6):844-6.
Karincaoglu Y, Kaya E, Esrefoglu M, Aydogdu I.Leuk Lymphoma. 2003 Jun;44(6):1063-5.
4- Disseminated lupus vulgaris and papulonecrotic tuberculid: case report.
Senol M, Ozcan A, Aydin A, Karincaoglu Y, Sasmaz S, Sener S.Pediatr Dermatol. 2000 Mar-Apr;17(2):133-5.
3- Tularemia: a case transmitted from a sheep.
Senol M, Ozcan A, Karincaoglu Y, Aydin A, Ozerol IH.Cutis. 1999 Jan;63(1):49-51.
2- Three cases of verrucous carcinoma.
Dogan G, Oram Y, Hazneci E, Ozen S, Karincaoğlu Y, Ciralik H.Australas J Dermatol. 1998 Nov;39(4):251-4.
1- Severe adverse skin reaction to chlorambucil in a patient with chronic lymphocytic leukemia.
Aydogdu I, Ozcan C, Harputluoglu M, Karincaoglu Y, Turhan O, Ozcanu A.Anticancer Drugs. 1997 Jun;8(5):468-9.